REFERENCES:

1.       Adams MR, McCredie R, Jessup W, Robinson J, Sullivan D, Celermajer DS. Oral L-arginine improves
endothelium-dependent dilatation and reduces monocyte adhesion to endothelial cells in young men with
coronary artery disease. Atherosclerosis 1997 Mar 21; 129(2):261-9.

2.       Slawinski M, Grodzinska L, Kostka-Trabka E, Bieron K, Goszcz A, Gryglewski RJ. L-Arginine - substrate for NO synthesis - its beneficial effects in therapy of patients with peripheral arterial disease: comparison with placebo - preliminary results. Acta Physiol Hung 1996; 84(4):457-8.

3.       Visek WJ. Arginine needs, physiological state, and usual diets. J Nutr 1986;116:36-46.

4.       Watanabe G, Tomiyama H, Doba N. Effects of oral administration of L-arginine on renal function in patients with heart failure. J Hypertens 2000 Feb;18(2):229-34.

5.       Koifman B, Wollman Y, Bogomolny N, Chernichowsky T, Finkelstein A, Peer G, Scherez J, Blum M, Laniado S,
Iaina A, et al. Improvement of cardiac performance by intravenous infusion of l-arginine in patients
with moderate congestive heart failure. J Am Coll Cardiol 1995 Nov 1;26(5):1251-6.

6.       Rector TS, Bank AJ, Mullen KA, Tschumperlin LK, Sih R, Pillai K, Kubo SH. Randomized, double-blind, placebo-controlled study of supplemental oral L-arginine in patients with heart failure.
Circulation 1996 Jun 15;93(12):2135-41.

7.       Rector TS, Bunk AJ, Mullen KA et al. Randomized, double-blind, placebo-controlled study of
supplemental oral L-arginine in patients with heart failure. Circ 1996;93:2135-41.

8.       Hambrecht R, Fiehn E, Weigl C, et al. Regular physical exercise corrects endothelial dysfunction
and improves exercise capacity in patients with chronic heart failure. Circ 1998;98:2709-15.

9.       Drexler H. Endothelial dysfunction. Prog Cardiovasc Dis 1997 Jan-Feb;39(4):287-324.

10.   Hambrecht R, Hilbrich L, Erbs S, Gielen S, Fiehn E, Schoene N, Schuler G. Correction of
endothelial dysfunction in chronic heart failure: additional effects of exercise training
and oral L-arginine supplementation. J Am Coll Cardiol 2000;35(3):706-13.

11.   Bachmann S, Mundel P. Nitric oxide in the kidney: synthesis, localization, and function.
Am J Kidney Dis 1994 Jul;24(1):112-29.

12.   Aiello S, Remuzzi G, Noris M. Nitric oxide/endothelin balance after nephron
reduction.Kidney Int Suppl 1998 Apr;65:S63-7.
 

13.   Wascher et al. Effects of low-dose L-arginine on insulin-mediated vasodilation
and insulin sensitivity. Eur J Clin Invest 1997;27:690-5.

14.   Beale RJ, Bryg DJ, Bihari DJ. Immunonutrition in the critically ill:a
systematic review of clinical outcome.Crit Care Med '99 Dec 27(12):2799-805.
 

Copyright 2012-2020 Betty Clarke.
All Rights Reserved.